Turkey Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026
Turkey Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026
SUMMARY
Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Turkish pharmaceuticals market had total revenues of $7.5 billion in 2021, representing a compound annual growth rate (CAGR) of 0.8% between 2016 and 2021.
- Very strong growth in previous years was a result of greater urbanization and easier access to medication. The Health Transportation program was launched in 2003 to improve hospital infrastructure and utilize the latest technology.
- Like many European countries, Turkey has witnessed growing demand among policy makers for cheaper, generic substitutes to originator drugs. This could impede growth in the market, given that generic substitutes are typically cheaper than branded products.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Turkey
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Turkey
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts
- What was the size of the Turkey pharmaceuticals market by value in 2021?
- What will be the size of the Turkey pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the Turkey pharmaceuticals market?
- How has the market performed over the last five years?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent partnerships?
7.5. Are there any threats towards leading players?
7.6. Are there any government regulations which are having an impact on the market?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Sanofi SA
8.3. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent partnerships?
7.5. Are there any threats towards leading players?
7.6. Are there any government regulations which are having an impact on the market?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Sanofi SA
8.3. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Turkey pharmaceuticals market value: $ billion, 2016–21
Table 2: Turkey pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Turkey pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Turkey pharmaceuticals market share: % share, by value, 2021
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: Annual Financial Ratios
Table 11: Sanofi SA: Key Employees
Table 12: Sanofi SA: Key Employees Continued
Table 13: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
Table 14: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: Turkey size of population (million), 2017–21
Table 20: Turkey gdp (constant 2005 prices, $ billion), 2017–21
Table 21: Turkey gdp (current prices, $ billion), 2017–21
Table 22: Turkey inflation, 2017–21
Table 23: Turkey consumer price index (absolute), 2017–21
Table 24: Turkey exchange rate, 2017–21
Table 1: Turkey pharmaceuticals market value: $ billion, 2016–21
Table 2: Turkey pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Turkey pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Turkey pharmaceuticals market share: % share, by value, 2021
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: Annual Financial Ratios
Table 11: Sanofi SA: Key Employees
Table 12: Sanofi SA: Key Employees Continued
Table 13: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
Table 14: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: Turkey size of population (million), 2017–21
Table 20: Turkey gdp (constant 2005 prices, $ billion), 2017–21
Table 21: Turkey gdp (current prices, $ billion), 2017–21
Table 22: Turkey inflation, 2017–21
Table 23: Turkey consumer price index (absolute), 2017–21
Table 24: Turkey exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Turkey pharmaceuticals market value: $ billion, 2016–21
Figure 2: Turkey pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Turkey pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Turkey, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Turkey, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Turkey, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2021
Figure 10: Turkey pharmaceuticals market share: % share, by value, 2021
Figure 1: Turkey pharmaceuticals market value: $ billion, 2016–21
Figure 2: Turkey pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Turkey pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Turkey, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Turkey, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Turkey, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2021
Figure 10: Turkey pharmaceuticals market share: % share, by value, 2021
